openPR Logo
Press release

Viscosupplementation Market Global Recent Trend, Strategy Profiling, Growing CAGR Value, Technology Advancement Future Growth Insights by 2028 | Ferring B.V., Fidia Farmaceutici S.P.A, Bioventus Inc.

08-10-2021 11:46 AM CET | Health & Medicine

Press release from: The Insight Partners

Viscosupplementation Market

Viscosupplementation Market

Viscosupplementation is a method in which a thick fluid called hyaluronate is injected into the knee joint. There are no remedies for osteoarthritis, so viscosupplementation will not counteract osteoarthritis of the knee. However, it is claimed that hyaluronate helps in improving the lubricating properties of the synovial fluid, lessen the pain from osteoarthritis of the knee, improves mobility, and provide a higher and more convenient level of activity. Viscosupplementation is a minimally invasive procedure which involves injection of gel-like substance. Currently hyaluronate injections are only approved viscosupplementation therapy of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues.

The global ‘Viscosupplementation Market’ report provides a detailed evaluation of the market – this includes the major trends, basic market driving factors, main challenges, enabling technologies, regulatory landscape, standardization, future roadmap, growth opportunities, value chain, ecosystem player profiles and strategies. The report also presents the projections for Viscosupplementation investments from 2020 till 2028.

The global Viscosupplementation research report delivers an overall outlook of the market. It explains the changing dynamics of this market, value chain, deployments, restraining parameters, as well as market dynamic forces of the Viscosupplementation Industry.

To get a sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://bit.ly/3s5WAOW

Key players profiled in the report include:

 Bioventus Inc.
 Anika Therapeutics
 Seikagaku Corporation
 Zimmer Biomet
 Smith & Nephew PLC
 Ferring B.V.
 Lifecore Biomedical, LLC (Landec)
 Salix Pharmaceuticals
 Fidia Farmaceutici S.P.A
 LG Life Sciences Ltd.

The report basically aims to present an overall analysis of the market and is inclusive of highly thoughtful insights, historical data, experiences, industry-validated data, and projections alongside a given set of theories and methodology. The report depicts the competitive spectrum of the market in detail and also presents an in-depth comprehensive evaluation of the vital industry players.

The estimates pertaining to the CAGR (Compound Annual Growth Rate) have been calculated by the Global Viscosupplementation Market 2020 report with respect to the extent of the specific time duration. Industry specialists that have been evaluating the business environment are also likely to take a closer look at the alignment of the organization as well as the firm’s business structure. This data that has been collected has been done so based on the high-quality insights and market structures and more.

A SWOT analysis of the market has been presented in the report. The Viscosupplementation Market study also explores varied topics such as the regional market scope, products, suitable applications, market size pertaining to the individual product type, revenue and sales with respect to the region, manufacturing chain details, production cost analysis, an analysis of the parameters impacting the business, market size projection, etc.

Scope of the Report:

The "Global Viscosupplementation Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of viscosupplementation market with detailed market segmentation by course of treatment, anatomy, end user, and geography. The global viscosupplementation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading viscosupplementation market players and offers key trends and opportunities in the market.

An Overview of the Viscosupplementation Market:

The report incorporates the important regions that are a part of the geographical landscape of the Viscosupplementation Market. This has been segmented into Europe, China, the USA, Japan, South East Asia, and India.

Information pertaining to the industry valuation of every region as well as the anticipated growth rate expected to be registered by every geography during the projected timeline have been presented in the report.

The research report is inclusive of the information pertaining to the industry bigshots, that have expanded their business scope across most global regions as well as region-wise sales volume.

Details about market revenue and regional consumption have also been provided.

Regional Analysis Covers:

The Middle East and Africa Viscosupplementation Market (UAE, Egypt, Saudi Arabia, South Africa, Nigeria)
North America Viscosupplementation Market (Canada, Mexico, U.S.)
Asia Pacific Viscosupplementation Market (India, China, Korea, Southeast Asia)
South America Viscosupplementation Market (Argentina, Brazil, Colombia)
Europe Viscosupplementation Market (UK, Italy, Germany, France, Russia)

MARKET SEGMENTATION

The global viscosupplementation market is segmented on the basis of course of treatment, anatomy and end user. Based on course of treatment, the market is segmented as Single Injection and multiple injection. Based on Anatomy, the market is segmented as Knee Osteoarthritis, Hip Osteoarthritis, Ankle Osteoarthritis and Shoulder Osteoarthritis. On the basis of end user, the global viscosupplementation market is segmented into hospitals, clinics, and ambulatory service centers.

Interested in purchasing this Report?  Click here @ https://bit.ly/3ivPDn8

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viscosupplementation Market Global Recent Trend, Strategy Profiling, Growing CAGR Value, Technology Advancement Future Growth Insights by 2028 | Ferring B.V., Fidia Farmaceutici S.P.A, Bioventus Inc. here

News-ID: 2350852 • Views:

More Releases from The Insight Partners

Green Building Materials Market Forecast 2031: Valued at US$ 791.93 Billion, Growing at 10.4% CAGR
Green Building Materials Market Forecast 2031: Valued at US$ 791.93 Billion, Gro …
The Green Building Materials Market size is expected to reach US$ 791.93 billion by 2031. The market is anticipated to register a CAGR of 10.4% during 2025-2031. Global Green Building Materials Market 2031 Report give our customers an exhaustive and top to bottom examination of Green Building Materials Market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division,
Text Analytics Market Growth Forecast: Valued at US$ 29.53 Billion by 2031
Text Analytics Market Growth Forecast: Valued at US$ 29.53 Billion by 2031
The Text Analytics Market is evolving rapidly, fueled by breakthroughs in artificial intelligence, natural language processing, and the exploding volume of unstructured data from social media, customer feedback, and enterprise communications. Businesses worldwide are turning to text analytics solutions to unlock hidden insights, enhance customer experiences, and drive data-informed strategies. As organizations navigate complex data landscapes, text analytics stands out as a critical tool for competitive advantage. Download PDF: -https://www.theinsightpartners.com/sample/TIPTE100000198?utm_source=Openpr&utm_medium=10413 In today's
Genome Editing Market: Trends, Opportunities, and Future Outlook
Genome Editing Market: Trends, Opportunities, and Future Outlook
The genome editing market has emerged as one of the most dynamic and transformative sectors in biotechnology, driven by advancements in genetic engineering technologies and increasing applications across various fields. As of 2024, the market is witnessing significant growth, fueled by the rising demand for personalized medicine, agricultural innovations, and therapeutic solutions. This article explores the current trends, opportunities, and future outlook of the genome editing market. Get the sample request
Transdermal Drug Delivery System Market to Reach US$ 51,949.74 Million by 2030
Transdermal Drug Delivery System Market to Reach US$ 51,949.74 Million by 2030
The Transdermal Drug Delivery System Market is entering a new era of growth, driven by rising demand for non-invasive drug administration, patient-friendly therapies, and technological innovation. According to industry analysis, the market size is expected to grow from US$ 37,230.28 million in 2022 to US$ 51,949.74 million by 2030, recording a CAGR of 4.3% during 2022-2030. This trajectory highlights the increasing adoption of transdermal patches, gels, sprays, and other advanced

All 5 Releases


More Releases for Viscosupplementation

Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boost
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in
The three injection viscosupplementation product type segment is projected to be …
Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia